Preliminary and First-year results (international publications)

MANAGEMENT OF RETİNİTİS PİGMENTOSA BY WHARTON’S JELLY DERİVED MESENCHYMAL STEM CELLS: PRELİMİNARY CLİNİCAL RESULTS.

RETINITIS PIGMENTOSA – STARGARDT DISEASE – INHERITED RETINAL DEGENERATIONS – BEST DISEASE – OPTIC NERVE ATROPHY (PRP GROWTH FACTOR INJECTIONSMAGNOVISION THERAPYPHOTOBIOMODULATION THERAPY)

OPTIC NERVE DISEASE (STEM CELL, ELECTROMAGNETIC STIMULATION)

RETINITIS PIGMENTOSA TERMINAL STAGE (ARGUS II RETINAL PROSTHESIS OPERATION)

RETINAL TEAR AND RETINAL DETACHMENT ( 3D DIGITAL / ENDOSCOPIC / SMALL INCISION PARS PLANA VITRECTOMY SURGERY )

AGE RELEATED MACULAR DEGENERATION (INTRAVITREAL ANTIVEGF INJECTIONS – PRP GROWTH FACTOR INJECTIONS AND MAGNOVISION THERAPY)

DIABETIC RETINOPATHY ( INTRAVITREAL ANTIVEGF/OZURDEX INJECTIONS – MICROPULSE = SUBLIMINAL LASER PHOTOSTIMULATIONPRP GROWTH FACTOR INJECTIONS AND MAGNOVISION THERAPY )

CENTRAL SEROUS CHOROIDORETINOPATHY (MICROPULSE = SUBLIMINAL LASER –PHOTODYNAMIC THERAPY– PRP GROWTH FACTOR INJECTIONS)

LASER  FLOATER REMOVAL (ELLEX ULTRA Q REFLEX LASER VITREOLYSIS)

YELLOW WAVELENGTH PATTEN SCAN LASER TREATMENT

CATARACT (PHACOEMULSIFICATION – IOL)

GLAUCOMA (MICROPULSE = SUBLIMINAL LASER TRABECUOLOPLASTY – DIODE LASER CYCLOPHOTOCOAGULATION – LASER IRIDOTOMY – PRP GROWTH FACTOR INJECTIONS– MAGNOVISION THERAPY)

Contact : eozmert56@gmail.com

BİORETİNA NEORAMA OFİS 55-56 YAŞAM CADDESİ NO:13 SÖĞÜTÖZÜ
TOBB ETÜ HASTANESİ YANI
BEŞTEPE / ANKARA

Phone : +90 312 468 95 46 – 47